SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1
Document Type: EX-3.7
Date Filed: 2026-02-12
Accession Number: 0001493152-26-006407
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226006407/ex3-7.htm

Chunk 0 of 7
Word Count: 1465
Character Count: 9055

Document Content:

Exhibit

CERTIFICATE
OF DESIGNATIONS OF

THE
RIGHTS, PREFERENCES AND PRIVILEGES OF THE

SERIES
A-1 PREFERRED STOCK OF BIOVENTRIX, INC.

Pursuant
to Sections 103 and 151of

The
General Corporation Law of the State of Delaware

Bioventrix,
Inc. (the “Corporation”), a corporation organized and existing under the laws of the State of Delaware,
DOES HEREBY CERTIFY:

FIRST:
The Corporation’s Amended and Restated Certificate of Incorporation of the Corporation (the “Restated Certificate”)
was filed with the Secretary of State of the State of Delaware on August 8, 2016.

SECOND:
Article Fourth B. of the Restated Certificate authorizes the Board of Directors of the Corporation (the “Board”)
to determine, by resolutions duly adopted by the Board, the issuance of the remaining unissued and undesignated shares of Preferred Stock
in one or more classes or series, and to fix for each such powers, preferences, privileges and rights and such qualifications, limitations
or restrictions thereof, as shall be stated and expressed in the resolutions adopted by the Board providing for the issuance of such
class or series and as may be permitted by the Delaware General Corporation Law (the “DGCL”).

THIRD:
Pursuant to and under the authority granted the Board by Article Fourth B. of the Restated Certificate, the Board duly adopted, pursuant
to a unanimous written consent effective July 25, 2017, resolutions providing for the authorization of 250,000 shares of a new Series
A-1 Preferred Stock from the authorized but undesignated Preferred Stock of the Corporation, with the powers, preferences, privileges
and rights and the qualifications, limitations and restrictions as stated in EXHIBIT A attached hereto.

FOURTH:
In accordance with, and pursuant to, Section 103 and 151 of the DGCL, the Board has deemed it in the best interests of the Corporation,
and has authorized and directed the officers of the Corporation, to file with the Delaware Secretary of State this Certificate of Designations
of the Rights, Preferences and Privileges of the Series A-1 Preferred Stock.

WITNESS WHEREOF, the Corporation has caused this Certificate of Designations of the Rights, Privileges and Preferences of the Series
A-1 Preferred Stock to be signed by Kenneth Miller, its President, a duly authorized officer of
the Corporation, on July 25, 2017.

Kenneth Miller

Kenneth
Miller, President

EXHIBIT

STATEMENT
OF RIGHTS, PREFERENCES AND PRIVILEGES OF THE SERIES A-1 PREFEREED STOCK OF BIOVENTRIX, INC.

The
following is a statement of the designation and the rights, preferences and privileges, and the qualifications, limitations or restrictions
thereof in respect of the Series A-1 Preferred Stock of the Corporation.

1. Dividends.

From
and after the date of the issuance of any shares of Series A-1 Preferred Stock, dividends at the rate per annum of $9.00 per share shall
accrue on such shares of Series A-1 Preferred Stock (subject to appropriate adjustment in the event of any stock dividend, stock split,
combination or other similar recapitalization with respect to the Series A-1 Preferred Stock) (the “Accruing Dividends”).
Accruing Dividends will be payable by delivery of additional Series A-1 Preferred Shares only. When declared by the Board, the Company
shall deliver to each holder of Series A-1 Preferred Stock a number of Series A-1 Preferred Stock equal to the aggregate dividend payable
to such holder with respect to the Series A-1 Preferred Stock held by such holder as of the end of the quarter preceding such dividend
payment date divided by the then-applicable Series A-1 Conversion Price. Accruing Dividends shall accrue quarterly, whether or not declared,
and shall be cumulative. The Corporation shall not declare, pay or set aside any dividends on shares of any other class or series of
capital stock of the Corporation (other than dividends on shares of Common Stock payable in shares of Common Stock) unless the holders
of the Series A-1 Preferred Stock then outstanding shall first receive, on a pari passu basis with any dividends payable to the holders
of Series A Preferred Stock, or simultaneously receive, a dividend on each outstanding share of Series A-1 Preferred Stock in an amount
equal to the amount at least equal to the greater of (i) the amount of the aggregate Accruing Dividends then accrued on such share of
Series A-1 Preferred Stock and not previously paid and (ii) (A) in the case of a dividend on Common Stock or any class or series that
is convertible into Common Stock, that dividend per share of Series A-1 Preferred Stock as would equal the product of (1) the dividend
payable on each share of such class or series determined, if applicable, as if all shares of such class or series had been converted
into Common Stock and (2) the number of shares of Common Stock issuable upon conversion of a share of Series A-1 Preferred Stock, in
each case calculated on the record date for determination of holders entitled to receive such dividend or (B) in the case of a dividend
on any class or series that is not convertible into Common Stock, at a rate per share of Series A-1 Preferred Stock determined by (1)
dividing the amount of the dividend payable on each share of such class or series of capital stock by the original issuance price of
such class or series of capital stock (subject to appropriate adjustment in the event of any stock dividend, stock split, combination
or other similar recapitalization with respect to such class or series) and (2) multiplying such fraction by an amount equal to the Series
A-1 Original Issue Price (as defined below); provided that if the Corporation declares, pays or sets aside, on the same date, a dividend
on shares of more than one class or series of capital stock of the Corporation, the dividend payable to the holders of Series A-1 Preferred
Stock pursuant to this Section 1 shall be calculated based upon the dividend on the class or series of capital stock that would result
in the highest Series A-1 Preferred Stock dividend.

2. Liquidation,
Dissolution or Winding Up; Certain Mergers, Consolidations and Asset Sales.

2.1 Preferential
Payments to Holders of Series A-1Preferred Stock. In the event of any voluntary or involuntary liquidation, dissolution or winding
up of the Corporation or Deemed Liquidation Event, the holders of shares of Series A-1 Preferred Stock then outstanding shall be entitled
to be paid out of the assets of the Corporation available for distribution to its stockholders on a pari passu with the holders of shares
of Series A Preferred Stock before any payment shall be made to the holders of Common Stock by reason of their ownership thereof, an
amount per share equal to the greater of (i) one and one-quarter (1.25) times the Series A-1 Original Issue Price, plus any dividends
accrued but unpaid thereon, or (ii) such amount per share as would have been payable had all shares of Series A-1 Preferred Stock been
converted into Common Stock pursuant to Section 4 immediately prior to such liquidation, dissolution, winding up or Deemed Liquidation
Event (the amount payable pursuant to this sentence is hereinafter referred to as the “Series A-1 Liquidation Amount”).
If upon any such liquidation, dissolution or winding up of the Corporation or Deemed Liquidation Event, the assets of the Corporation
available for distribution to its stockholders shall be insufficient to pay the holders of shares of Series A-1 Preferred Stock the full
amount to which they shall be entitled under this Subsection 2.1, the holders of shares of Series A-1 Preferred Stock shall share
ratably in any distribution of the assets available for distribution in proportion to the respective amounts which would otherwise be
payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid
in full. The “Series A-1 Original Issue Price” shall mean $100 per share, subject to appropriate adjustment in the
event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Series A-1 Preferred Stock.

2.2 Payments
to Holders of Common Stock. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation
or Deemed Liquidation Event, after the payment of all preferential amounts required to be paid to the holders of shares of Series A-1
Preferred Stock and the holders of shares of Series A Preferred Stock, the remaining assets of the Corporation available for distribution
to its stockholders shall be distributed among the holders of shares of Common Stock, pro rata based on the number of shares held by
each such holder.

2.3 Deemed
Liquidation Events.

2.3.1 Definition.
Each of the following events shall be considered a “Deemed Liquidation Event”:

merger or consolidation in which

(i)	the
Corporation is a constituent party or

subsidiary of the Corporation is a constituent party and the Corporation issues shares of
its capital stock pursuant to such merger or consolidation,